A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers

Lin C.Chen D.-R.KING-JEN CHANGChang T.-W.Wang H.-C.2022-08-122022-08-1220120344-5704https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862270671&doi=10.1007%2fs00280-012-1841-y&partnerID=40&md5=48c2955f7f8d4821a890e14319273f65https://scholars.lib.ntu.edu.tw/handle/123456789/616652A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancersjournal article10.1007/s00280-012-1841-y223499222-s2.0-84862270671